Clinical trial Recruiting at 1 site Interventional Ages 3 to 18

Improving mental health access for children at risk of trauma

Official title: Family Connections: A Community-Based Approach to Expanding Mental Health Access and Engagement for SED Youth

Run by Cambridge Health Alliance · NCT06662357 · Data updated 2026-11-12

This study is testing a new program that helps children aged 3 to 18 who are at risk for trauma get better access to mental health support and care.

More Behavior Disorders trials

Quick facts

Study typeInterventional
Ages3 Years to 18 Years
SexAll
Enrollment300 (estimated)
SponsorCambridge Health Alliance
Academic / other
Locations1 site (Cambridge, Massachusetts)
StatusRecruiting
StartedJanuary 30, 2025
Main results expectedJuly 2028
Study endsSeptember 29, 2028
Registry record updatedOctober 22, 2026
Trial IDNCT06662357 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this initiative are children aged 3 to 18 who are enrolled in MassHealth and have been referred by their primary care physician due to concerns about mental health or substance use.

Probably not a fit

Patients who are not enrolled in MassHealth or are over the age of 17.5 years will not benefit from this initiative.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Family Connections initiative aims to address disparities in mental health treatment access for children aged 3 to 18 who are at risk for childhood trauma and serious emotional disturbances. This program utilizes mobile clinical and family support teams to enhance mental health outcomes for these children. By integrating care within the Cambridge Health Alliance system, the initiative seeks to provide comprehensive assessments and interventions for those identified with mental health or substance use needs. The approach is designed to be innovative and responsive to the unique challenges faced by at-risk youth.

Why it matters

Potential benefit: If successful, this initiative could significantly improve mental health outcomes for children facing emotional disturbances and trauma.

How similar studies have gone: While this approach is innovative, similar initiatives targeting mental health access for children have shown promise in improving outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 3 through 18 years (17½ years maximum at time of enrollment)
* Referred by Primary Care Physician's (PCP) from one of the three Cambridge Health Alliance (CHA) primary care intervention sites to the Family Connections team for an integrated child mental health and/or substance use disorder clinical assessment.
* Positive screen on CHA's standard pediatric mental health and substance use screening instruments, and/or parental concern about possible mental health/substance use needs, and/or PCP concern about possible mental health/substance use needs
* Enrolled in MassHealth

Exclusion Criteria:

* Subjects over 17.5 years (SAMHSA data collection required at 6 and 12 months after enrollment which must occur before age 18 years.)
* Youth who are not enrolled in MassHealth
* CHA patients with PCP located at CHA primary care site other than the identified intervention sites

Where it's running

  • Cambridge Health Alliance
    Cambridge, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.